STAT3 activation confers trastuzumab‐emtansine (T‐DM1) resistance in HER2‐positive breast cancer

por Wang, Lei, Wang, Quanren, Gao, Mingzhao, Fu, Li, Li, Yun, Quan, Haitian, Lou, Liguang
Publicado 2018

Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants

por Gao, Mingzhao, Zhu, Hongmei, Fu, Li, Li, Yun, Bao, Xubin, Fu, Haoyu, Quan, Haitian, Wang, Lei, Lou, Liguang
Publicado 2019

SHR‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met...

por Tong, Mengya, Gao, Mingzhao, Xu, Yongping, Fu, Li, Li, Yun, Bao, Xubin, Fu, Haoyu, Quan, Haitian, Lou, Liguang
Publicado 2019

Pharmacologic characterization of fluzoparib, a novel poly(ADP‐ribose) polymerase inhibitor undergoing clinical trials

por Wang, Lei, Yang, Changyong, Xie, Chengying, Jiang, Jiahua, Gao, Mingzhao, Fu, Li, Li, Yun, Bao, Xubin, Fu, Haoyu, Lou, Liguang
Publicado 2019